Free Trial

Extendicare (TSE:EXE) Reaches New 12-Month High - What's Next?

Extendicare logo with Medical background
Remove Ads

Extendicare Inc. (TSE:EXE - Get Free Report)'s stock price reached a new 52-week high on Monday . The company traded as high as C$13.13 and last traded at C$13.08, with a volume of 67465 shares. The stock had previously closed at C$13.04.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. TD Securities boosted their target price on Extendicare from C$10.50 to C$13.00 and gave the company a "hold" rating in a research report on Monday, March 3rd. Cormark raised Extendicare to a "moderate buy" rating in a research note on Wednesday, February 19th. Royal Bank of Canada boosted their price target on shares of Extendicare from C$9.50 to C$11.00 and gave the stock a "sector perform" rating in a research note on Thursday, November 28th. Finally, BMO Capital Markets increased their price target on shares of Extendicare from C$11.00 to C$13.50 in a research report on Monday, March 3rd.

View Our Latest Stock Analysis on Extendicare

Extendicare Stock Down 1.1 %

The business has a 50-day simple moving average of C$11.09 and a 200-day simple moving average of C$10.05. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62. The company has a market cap of C$1.06 billion, a price-to-earnings ratio of 16.26 and a beta of 1.26.

Extendicare Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 17th will be issued a dividend of $0.04 per share. This represents a $0.48 annualized dividend and a yield of 3.76%. The ex-dividend date of this dividend is Friday, February 28th. Extendicare's dividend payout ratio (DPR) is presently 61.20%.

Remove Ads

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

Recommended Stories

Should You Invest $1,000 in Extendicare Right Now?

Before you consider Extendicare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.

While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads